Tim Ullrich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tim Ullrich has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
- Gerald Antoch
Department of Diagnostic and Interventional Radiology, Medical Faculty, University Dusseldorf, 40225 Dusseldorf, Germany
17 shared publications - Lars Schimmöller
University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, Dusseldorf, Germany; Department of Diagnostic, Interventional Radiology and Nuclear Medicine, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany
17 shared publications - Peter Albers
Department of Urology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
14 shared publications - Christian Arsov
University Dusseldorf, Medical Faculty, Department of Urology, D-40225 Dusseldorf, Germany
12 shared publications - Michael Quentin
University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, D-40225 Dusseldorf, Germany
12 shared publications - Matthias Boschheidgen
Department of Diagnostic and Interventional Radiology, Medical Faculty, University Dusseldorf, 40225 Dusseldorf, Germany
7 shared publications
Latest Publications
- Open Access
- 11 February 2025
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 118, 110358
Use of deep learning-accelerated T2 TSE for prostate MRI: Comparison with and without hyoscine butylbromide admission
- 11 February 2025
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 118, 110358
Open AccessUse of deep learning-accelerated T2 TSE for prostate MRI: Comparison with and without hyoscine butylbromide admission
- 14 December 2023
- Published by Elsevier in Clinical Radiology
- Vol. 79 (3) , e468-e474
Benefit of dynamic contrast-enhanced (DCE) imaging for prostate cancer detection depending on readers experience in prostate MRI
- 14 December 2023
- Published by Elsevier in Clinical Radiology
- Vol. 79 (3) , e468-e474
Benefit of dynamic contrast-enhanced (DCE) imaging for prostate cancer detection depending on readers experience in prostate MRI
- 7 April 2023
- Published by Elsevier in Clinical Imaging
- Vol. 99, 25-30
Contrast medium free selective adrenal vein sampling in the management of primary aldosteronism
- 7 April 2023
- Published by Elsevier in Clinical Imaging
- Vol. 99, 25-30
Contrast medium free selective adrenal vein sampling in the management of primary aldosteronism
- 14 January 2023
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 98, 55-61
Improved diffusion-weighted imaging of the prostate: Comparison of readout-segmented and zoomed single-shot imaging
- 14 January 2023
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 98, 55-61
Improved diffusion-weighted imaging of the prostate: Comparison of readout-segmented and zoomed single-shot imaging
- 13 September 2022
- Published by Elsevier in European Journal of Radiology
- Vol. 156, 110520
Impact of dynamic contrast-enhanced MRI in 1.5 T versus 3 T MRI for clinically significant prostate cancer detection
- 13 September 2022
- Published by Elsevier in European Journal of Radiology
- Vol. 156, 110520
Impact of dynamic contrast-enhanced MRI in 1.5 T versus 3 T MRI for clinically significant prostate cancer detection
- Open Access
- 16 May 2022
- Published by Springer Nature in Abdominal Radiology
- Vol. 47 (7) , 2486-2493
Pre-operative magnetic resonance imaging can predict prostate cancer with risk for positive surgical margins
Purpose: Analysis of patients with pre-operative 3 T multiparametric prostate MRI (mpMRI) to determine reliable MRI-based risk predictors of patients at risk for positive surgical margins (PSM) in robotic assisted radical prostatectomy (RPE). Methods: Consecutive patients with 3 T mpMRI and subsequent RPE from 01/2015 to 12/2018 were retrospectively included. Patients were compared regarding clinical and MRI related parameters such as length of capsular tumor contact (LCC) and distance to the membranous urethra (UD). Results: Forty-nine of 179 patients (27%) had PSM in 70 different localizations, with the majority located at the capsule (57%, 40/70), mostly apical and/or posterior. The second most often PSM occurred at the apical urethra (22%, 15/70). PCA was visible on mpMRI at the localization of PSM in 93% at the capsule and in 80% at the urethra. PSA, PI-RADS classification, extraprostatic extension (EPE), and seminal vesicles infiltration (SVI) on MRI were significantly higher / more frequent in patients with PSM. LCC (AUC 0.710), EPE (AUC 0.693), and UD (1-AUC 0.673) predicted PSM (overall). An UD of ≤ 3.5 mm showed the highest accuracy of 95% (J = 0.946) for PSM at the urethra and a LCC of ≥ 22.5 mm with 77% (J = 0.378) for PSM at the capsule. Conclusion: PSM occurred mostly in the apex and/or posteriorly at the capsule or at the apical urethra. LCC was the best MRI predictor for PSM at the capsule and UD for tumors with PSM at the apical urethra. Using these MRI parameters readers might pre-operatively determine PCA localizations at risk for PSM.
- 16 May 2022
- Published by Springer Nature in Abdominal Radiology
- Vol. 47 (7) , 2486-2493
Open AccessPre-operative magnetic resonance imaging can predict prostate cancer with risk for positive surgical margins
Purpose: Analysis of patients with pre-operative 3 T multiparametric prostate MRI (mpMRI) to determine reliable MRI-based risk predictors of patients at risk for positive surgical margins (PSM) in robotic assisted radical prostatectomy (RPE). Methods: Consecutive patients with 3 T mpMRI and subsequent RPE from 01/2015 to 12/2018 were retrospectively included. Patients were compared regarding clinical and MRI related parameters such as length of capsular tumor contact (LCC) and distance to the membranous urethra (UD). Results: Forty-nine of 179 patients (27%) had PSM in 70 different localizations, with the majority located at the capsule (57%, 40/70), mostly apical and/or posterior. The second most often PSM occurred at the apical urethra (22%, 15/70). PCA was visible on mpMRI at the localization of PSM in 93% at the capsule and in 80% at the urethra. PSA, PI-RADS classification, extraprostatic extension (EPE), and seminal vesicles infiltration (SVI) on MRI were significantly higher / more frequent in patients with PSM. LCC (AUC 0.710), EPE (AUC 0.693), and UD (1-AUC 0.673) predicted PSM (overall). An UD of ≤ 3.5 mm showed the highest accuracy of 95% (J = 0.946) for PSM at the urethra and a LCC of ≥ 22.5 mm with 77% (J = 0.378) for PSM at the capsule. Conclusion: PSM occurred mostly in the apex and/or posteriorly at the capsule or at the apical urethra. LCC was the best MRI predictor for PSM at the capsule and UD for tumors with PSM at the apical urethra. Using these MRI parameters readers might pre-operatively determine PCA localizations at risk for PSM.
- 29 April 2022
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 28 (2) , 108-114
Arterial input function for quantitative dynamic contrast-enhanced MRI to diagnose prostate cancer
PURPOSE This study aims to analyze the ability of quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to distinguish between prostate cancer (PCa) and benign lesions in transition zone (TZ) and peripheral zone (PZ) using different methods for arterial input function (AIF) determination. Study endpoints are identification of a standard AIF method and optimal quantitative perfusion parameters for PCa detection. METHODS DCE image data of 50 consecutive patients with PCa who underwent multiparametric MRI were analyzed retrospectively with three different methods of AIF acquisition. First, a region of interest was manually defined in an artery (AIFm); second, an automated algorithm was used (AIFa); and third, a population-based AIF (AIFp) was applied. Values of quantitative parameters after Tofts (Ktrans, ve, and kep) in PCa, PZ, and TZ in the three different AIFs were analyzed. RESULTS Ktrans and kep were significantly higher in PCa than in benign tissue independent from the AIF method. Whereas in PZ, Ktrans and kep could differentiate PCa (P < .001), in TZ only kep using AIFpdemonstrated a significant difference (P = .039). The correlations of the perfusion parameters that resulted from AIFm and AIFa were higher than those that resulted from AIFp, and the absolute values of Ktrans, kep, and ve were significantly lower when using AIFp. The values of quantitative perfusion parameters for PCa were similar regardless of whether PCa was located in PZ or TZ. CONCLUSION Ktrans and kep were able to differentiate PCa from benign PZ independent of the AIF method. AIFaseems to be the most feasible method of AIF determination in clinical routine. For TZ, none of the quantitative perfusion parameters provided satisfying results.
- 29 April 2022
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 28 (2) , 108-114
Arterial input function for quantitative dynamic contrast-enhanced MRI to diagnose prostate cancer
PURPOSE This study aims to analyze the ability of quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to distinguish between prostate cancer (PCa) and benign lesions in transition zone (TZ) and peripheral zone (PZ) using different methods for arterial input function (AIF) determination. Study endpoints are identification of a standard AIF method and optimal quantitative perfusion parameters for PCa detection. METHODS DCE image data of 50 consecutive patients with PCa who underwent multiparametric MRI were analyzed retrospectively with three different methods of AIF acquisition. First, a region of interest was manually defined in an artery (AIFm); second, an automated algorithm was used (AIFa); and third, a population-based AIF (AIFp) was applied. Values of quantitative parameters after Tofts (Ktrans, ve, and kep) in PCa, PZ, and TZ in the three different AIFs were analyzed. RESULTS Ktrans and kep were significantly higher in PCa than in benign tissue independent from the AIF method. Whereas in PZ, Ktrans and kep could differentiate PCa (P < .001), in TZ only kep using AIFpdemonstrated a significant difference (P = .039). The correlations of the perfusion parameters that resulted from AIFm and AIFa were higher than those that resulted from AIFp, and the absolute values of Ktrans, kep, and ve were significantly lower when using AIFp. The values of quantitative perfusion parameters for PCa were similar regardless of whether PCa was located in PZ or TZ. CONCLUSION Ktrans and kep were able to differentiate PCa from benign PZ independent of the AIF method. AIFaseems to be the most feasible method of AIF determination in clinical routine. For TZ, none of the quantitative perfusion parameters provided satisfying results.
- 1 February 2022
- Published by Elsevier in European Journal of Radiology
- Vol. 147, 110110
Comparison of 3 T mpMRI and pelvic CT examinations for detection of lymph node metastases in patients with prostate cancer
- 1 February 2022
- Published by Elsevier in European Journal of Radiology
- Vol. 147, 110110
Comparison of 3 T mpMRI and pelvic CT examinations for detection of lymph node metastases in patients with prostate cancer
- Open Access
- 17 January 2022
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 56 (2) , 413-422
Value of T2 Mapping MRI for Prostate Cancer Detection and Classification
Background: Currently, multi‐parametric prostate MRI (mpMRI) consists of a qualitative T2, diffusion weighted, and dynamic contrast enhanced imaging. Quantification of T2 imaging might further standardize PCa detection and support artificial intelligence solutions.Purpose: To evaluate the value of T2 mapping to detect prostate cancer (PCa) and to differentiate PCa aggressiveness.Study Type: Retrospective single center cohort study.Population: Forty‐four consecutive patients (mean age 67 years; median PSA 7.9 ng/mL) with mpMRI and verified PCa by subsequent targeted plus systematic MR/ultrasound (US)‐fusion biopsy from February 2019 to December 2019.Field Strength/Sequence: Standardized mpMRI at 3 T with an additionally acquired T2 mapping sequence.Assessment: Primary endpoint was the analysis of quantitative T2 values and contrast differences/ratios (CD/CR) between PCa and benign tissue. Secondary objectives were the correlation between T2 values, ISUP grade, apparent diffusion coefficient (ADC) value, and PI‐RADS, and the evaluation of thresholds for differentiating PCa and clinically significant PCa (csPCa).Statistical Tests: Mann–Whitney test, Spearman's rank (rs) correlation, receiver operating curves, Youden's index (J), and AUC were performed. Statistical significance was defined as P < 0.05.Results: Median quantitative T2 values were significantly lower for PCa in PZ (85 msec) and PCa in TZ (75 msec) compared to benign PZ (141 msec) or TZ (97 msec) (P < 0.001). CD/CR between PCa and benign PZ (51.2/1.77), respectively TZ (19.8/1.29), differed significantly (P < 0.001). The best T2‐mapping threshold for PCa/csPCa detection was for TZ 81/86 msec (J = 0.929/1.0), and for PZ 110 msec (J = 0.834/0.905). Quantitative T2 values of PCa did not correlate significantly with the ISUP grade (rs = 0.186; P = 0.226), ADC value (rs = 0.138; P = 0.372), or PI‐RADS (rs = 0.132; P = 0.392).Data Conclusion: Quantitative T2 values could differentiate PCa in TZ and PZ and might support standardization of mpMRI of the prostate. Different thresholds seem to apply for PZ and TZ lesions. However, in the present study quantitative T2 values were not able to indicate PCa aggressiveness.Level of Evidence: 2Technical Efficacy: Stage 2
- 17 January 2022
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 56 (2) , 413-422
Open AccessValue of T2 Mapping MRI for Prostate Cancer Detection and Classification
Background: Currently, multi‐parametric prostate MRI (mpMRI) consists of a qualitative T2, diffusion weighted, and dynamic contrast enhanced imaging. Quantification of T2 imaging might further standardize PCa detection and support artificial intelligence solutions.Purpose: To evaluate the value of T2 mapping to detect prostate cancer (PCa) and to differentiate PCa aggressiveness.Study Type: Retrospective single center cohort study.Population: Forty‐four consecutive patients (mean age 67 years; median PSA 7.9 ng/mL) with mpMRI and verified PCa by subsequent targeted plus systematic MR/ultrasound (US)‐fusion biopsy from February 2019 to December 2019.Field Strength/Sequence: Standardized mpMRI at 3 T with an additionally acquired T2 mapping sequence.Assessment: Primary endpoint was the analysis of quantitative T2 values and contrast differences/ratios (CD/CR) between PCa and benign tissue. Secondary objectives were the correlation between T2 values, ISUP grade, apparent diffusion coefficient (ADC) value, and PI‐RADS, and the evaluation of thresholds for differentiating PCa and clinically significant PCa (csPCa).Statistical Tests: Mann–Whitney test, Spearman's rank (rs) correlation, receiver operating curves, Youden's index (J), and AUC were performed. Statistical significance was defined as P < 0.05.Results: Median quantitative T2 values were significantly lower for PCa in PZ (85 msec) and PCa in TZ (75 msec) compared to benign PZ (141 msec) or TZ (97 msec) (P < 0.001). CD/CR between PCa and benign PZ (51.2/1.77), respectively TZ (19.8/1.29), differed significantly (P < 0.001). The best T2‐mapping threshold for PCa/csPCa detection was for TZ 81/86 msec (J = 0.929/1.0), and for PZ 110 msec (J = 0.834/0.905). Quantitative T2 values of PCa did not correlate significantly with the ISUP grade (rs = 0.186; P = 0.226), ADC value (rs = 0.138; P = 0.372), or PI‐RADS (rs = 0.132; P = 0.392).Data Conclusion: Quantitative T2 values could differentiate PCa in TZ and PZ and might support standardization of mpMRI of the prostate. Different thresholds seem to apply for PZ and TZ lesions. However, in the present study quantitative T2 values were not able to indicate PCa aggressiveness.Level of Evidence: 2Technical Efficacy: Stage 2
- 1 November 2021
- Published by Elsevier in European Journal of Radiology
- Vol. 144, 109949
Comparison and prediction of artefact severity due to total hip replacement in 1.5 T versus 3 T MRI of the prostate
- 1 November 2021
- Published by Elsevier in European Journal of Radiology
- Vol. 144, 109949
Comparison and prediction of artefact severity due to total hip replacement in 1.5 T versus 3 T MRI of the prostate